Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
Brittani R. Price, Tiffany L. Sudduth, Erica M. Weekman, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 94

Showing 1-25 of 94 citing articles:

Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology
Seung-Hye Lee, William J. Meilandt, Luke Xie, et al.
Neuron (2021) Vol. 109, Iss. 8, pp. 1283-1301.e6
Open Access | Times Cited: 184
Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer’s Disease
Joseph W. Lewcock, Kai Schlepckow, Gilbert Di Paolo, et al.
Neuron (2020) Vol. 108, Iss. 5, pp. 801-821
Open Access | Times Cited: 177
Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases
Urmi Sengupta, Rakez Kayed
Progress in Neurobiology (2022) Vol. 214, pp. 102270-102270
Open Access | Times Cited: 161
A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models
Bettina van Lengerich, Lihong Zhan, Dan Xia, et al.
Nature Neuroscience (2023)
Open Access | Times Cited: 128
TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target
Li Ruiyang, Qi Qin, Han-Chen Yang, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 110
Targeting neuroinflammation in Alzheimer’s disease: from mechanisms to clinical applications
Yu Liu, Zizhen Si, Chen-Jun Zou, et al.
Neural Regeneration Research (2022) Vol. 18, Iss. 4, pp. 708-708
Open Access | Times Cited: 105
Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
Jifei Miao, Haixia Ma, Yang Yang, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 88
Chronic TREM2 activation exacerbates Aβ-associated tau seeding and spreading
Nimansha Jain, Caroline A. Lewis, Jason D. Ulrich, et al.
The Journal of Experimental Medicine (2022) Vol. 220, Iss. 1
Open Access | Times Cited: 86
Soluble TREM2: Innocent bystander or active player in neurological diseases?
Fabia Filipello, Claire Goldsbury, Shih Feng You, et al.
Neurobiology of Disease (2022) Vol. 165, pp. 105630-105630
Open Access | Times Cited: 84
Role of Microglia and Astrocytes in Alzheimer’s Disease: From Neuroinflammation to Ca2+ Homeostasis Dysregulation
Giulia Di Benedetto, Chiara Burgaletto, Carlo Maria Bellanca, et al.
Cells (2022) Vol. 11, Iss. 17, pp. 2728-2728
Open Access | Times Cited: 83
A tetravalent TREM2 agonistic antibody reduced amyloid pathology in a mouse model of Alzheimer’s disease
Peng Zhao, Yuanzhong Xu, Lu-Lin Jiang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 661
Closed Access | Times Cited: 71
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney
Drugs (2023) Vol. 83, Iss. 15, pp. 1387-1408
Open Access | Times Cited: 64
Targeting synapse function and loss for treatment of neurodegenerative diseases
Borislav Dejanovic, Morgan Sheng, Jesse E. Hanson
Nature Reviews Drug Discovery (2023) Vol. 23, Iss. 1, pp. 23-42
Closed Access | Times Cited: 44
Passive immunotherapy for Alzheimer's disease
Xiaoyi Guo, Yan Li, Denghong Zhang, et al.
Ageing Research Reviews (2024) Vol. 94, pp. 102192-102192
Open Access | Times Cited: 24
Microglia and amyloid plaque formation in Alzheimer's disease – Evidence, possible mechanisms, and future challenges
Stefanie Fruhwürth, Henrik Zetterberg, Søren R. Paludan
Journal of Neuroimmunology (2024) Vol. 390, pp. 578342-578342
Open Access | Times Cited: 19
Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
Guimei Zhang, Zicheng Wang, Huiling Hu, et al.
Frontiers in Cellular Neuroscience (2021) Vol. 15
Open Access | Times Cited: 87
The role of the immune system in Alzheimer’s disease
Kaimin Wu, Ya-Ru Zhang, Yu‐Yuan Huang, et al.
Ageing Research Reviews (2021) Vol. 70, pp. 101409-101409
Closed Access | Times Cited: 78
TLR4 Targeting as a Promising Therapeutic Strategy for Alzheimer Disease Treatment
Yongji Zhou, Yanxing Chen, Congcong Xu, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 77
New Insights into Neuroinflammation Involved in Pathogenic Mechanism of Alzheimer’s Disease and Its Potential for Therapeutic Intervention
Tiantian Li, Li Lu, Eloise Pember, et al.
Cells (2022) Vol. 11, Iss. 12, pp. 1925-1925
Open Access | Times Cited: 62
The niacin receptor HCAR2 modulates microglial response and limits disease progression in a mouse model of Alzheimer’s disease
Miguel Moutinho, Shweta S. Puntambekar, Andy P. Tsai, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 637
Open Access | Times Cited: 61
Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency
Anika Reifschneider, Sophie Robinson, Bettina van Lengerich, et al.
The EMBO Journal (2022) Vol. 41, Iss. 4
Open Access | Times Cited: 56
Neuroinflammation as a Potential Therapeutic Target in Alzheimer’s Disease
Ping Liu, Yunyun Wang, Yan Sun, et al.
Clinical Interventions in Aging (2022) Vol. Volume 17, pp. 665-674
Open Access | Times Cited: 54
Stimulation of TREM2 with agonistic antibodies—an emerging therapeutic option for Alzheimer's disease
Kai Schlepckow, Estrella Morenas‐Rodríguez, Soyon Hong, et al.
The Lancet Neurology (2023) Vol. 22, Iss. 11, pp. 1048-1060
Open Access | Times Cited: 36
Exploring Advancements in Early Detection of Alzheimer's Disease with Molecular Assays and Animal Models
Papihra Sethi, Rakesh Bhaskar, Krishna Kumar Singh, et al.
Ageing Research Reviews (2024) Vol. 100, pp. 102411-102411
Closed Access | Times Cited: 15
Trem2 Agonist Reprograms Foamy Macrophages to Promote Atherosclerotic Plaque Stability—Brief Report
Michael T. Patterson, Yingzheng Xu, Hannah Hillman, et al.
Arteriosclerosis Thrombosis and Vascular Biology (2024) Vol. 44, Iss. 7, pp. 1646-1657
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top